U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279155) titled 'A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans' on Dec. 01.
Brief Summary: This study aims to investigate the pharmacokinetics of bupivacaine liposomal injection (test preparation) in healthy subjects. The manufactured liposomal bupivacaine injection (EXPAREL(R)) was used as the reference formulation to evaluate the human bioequivalence between the two formulations.
Study Start Date: June 09
Study Type: INTERVENTIONAL
Condition:
Postoperative Local Analgesia
Intervention:
DRUG: Bupivacaine Liposome Injection T preparation
Bupivacaine Liposome Injection T preparation
DRUG: Bupivacaine Liposome Injec...